Navigation Links
Scientists discover a mechanism that can send cells on the road to cancer
Date:4/22/2008

ey hypothesized that the answer could be found in the activity of yet another protein, called Myc, which Dr. Tansey has spent much of his career studying. Myc is an oncoprotein: one that is important in a great many regulatory processes in the cell, and which, when overexpressed, can cause dysregulation that leads to cancer.

Prior work had shown that when E1A was present in a cell, the potentially dangerous Myc protein was stable -- it did not degrade naturally. In new experiments, Tansey and colleagues found that E1As stabilization of the Myc protein was accomplished not, as was suspected by some, by directly inhibiting its degradation in a cellular component called the proteosome, which destroys proteins. Rather, E1A stabilized Myc by promoting its binding with p400.

To recap the complex sequence of events: E1A, when present in a cell, binds to p400. That protein, in turn, forms a complex with Myc which accounts for Mycs stability in cells in which E1A is present. Close study showed that the piece of the E1A protein that was important for stabilizing Myc was the same piece that bound to p400, Dr. Tansey said. And just as E1A can pull the Rb protein away from E2F, initiating a cascade of pathologies potentially leading to oncogenesis, so does the ability of E1A to bind p400 -- and via that connection to engage Myc -- stabilize that oncoprotein and open the door to tumorigenesis.

We know now that the interaction of E1A and p400 is very important in terms of regulating cell growth in normal and cancer cells, Dr. Tansey said. So were taking a cue from the history of work on adenoviruses and were leaving E1A behind to concentrate on Myc and p400. For us, now, the next step is to learn more about the p400-Myc connection.


'/>"/>

Contact: Jim Bono
bono@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists identify novel way to prevent cardiac fibrosis
2. Scientists Explore Human Gene Pool With Help From Microsoft Research
3. Scientists obtain anticancer medicines from the elecampe, a wild plant growing in the Mediterranean
4. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
5. With annual deaths from malaria on the rise: Scientists ask where is all the money going?
6. Stem cells and cancer: Scientists investigate a fine balancing act
7. Scientists Block Prostate Cancer Cells Spread
8. Scientists solve mystery of polyketide drug formation
9. Scientists Uncover How HIV Hides Inside Cells
10. Scientists: New technique identifies molecular biomarkers for disease
11. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...wed Banzel proved effective against Lennox-Gastaut... News) -- A new drug called Banzel (rufinamide) ha... severe form of epilepsy called Lennox-Gastaut syn...nced Friday. , The approval was based on result...ients ages 4 to 30. Compared to patients who took ...
(Date:11/21/2008)..., W.Va., Nov. 21 New re...whether a smokeless, spitless tobacco product aime...ers have found that RJ Reynolds, Camel Snus - tout...on - contains surprisingly high levels of nicotine...an most other snuff products," said Bruce Adkins o...
(Date:11/21/2008)...S.C., Nov. 21 U.S. News... Quality Assurance (NCQA) ranked BlueChoice(R) Hea...ica,s Best Health Plans(TM), published in U.S. New... The respected annual ranking ranks the nation,s b... satisfaction and NCQA accreditation scores. NCQA ...
(Date:11/21/2008)...N.J., Nov. 21 Barr Pharm...at its shareholders overwhelmingly approved the pr...ion of Barr by Teva Pharmaceuticals Industries Ltd...onstrated the overwhelming support of the transact...y, Barr,s Chairman and CEO. "We are pleased with t...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...IV infected individuals, India plans to ask one yo...country to // teach others about safe sex and HIV,...rs, or agricultural laborers or just be hanging ar...ujatha Rao, director general of India's National A...
... Ltd Tuesday launched its branded inhalation capsu...que combination of long acting Beta2-agonist Formo...luticasone, the inhalation capsule Avessa is avail...0 mcg, Avessa 500 mcg, depending on the severity o...
...orld Health Organization has suggested that doctor...s may work against SARS// in the event of the retu...as conducted during and after the 2003 outbreak th...t find much evidence of any treatments employed th...
...ics and the particular bacteria causing some patie... Wake Forest University Baptist Medical Center has...y target the germs. “We matched the best antibioti...teristics and the particular bugs that we have in ...
Other Medicine News:Health News:Treatment of SARS Still a Mystery 2Health News:By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment 2
(Date:11/19/2008)...v. 19 Posit Science Corporation,r...ociety for Neuroscience,Annual Conference in Wash...aining may benefit Baby Boomers. The computerized...) uses adaptive exercises that target auditory and... drive generalized,improvements in cognition by i...
(Date:11/19/2008)... did not achieve statistical significance , ,...- Pharmos Corporation (Nasdaq: PARS ) today anno...its topical NanoEmulsion (NE) drug delivery techno... , , The multi-center, randomized, double-b...ety and efficacy of the Company,s 3% Diclofenac Di...
(Date:11/19/2008)...., Nov. 19 Biotech scientists incr...icology research to better understand the effects ...tems, reports Genetic Engineering & Biotechno... in figuring out a new compound,s mechanism of act...ogy technique, according to the November 15 issue ...
(Date:11/19/2008)...ion Payment from Roche- , , MONTVALE, N.J.,...uticals Corp. (Nasdaq: MEMY ) today announced th...se 2 trial of R3487/MEM 3454, its lead alpha-7 nic...ssociated with schizophrenia (CIAS). The Company ...triggering a $5.0 million payment from its partner...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Depression during pregnancy can double risk of preterm delivery 5533 1Depression during pregnancy can double risk of preterm delivery 5533 2OrbitalPay LLC Implements Zecures Acquirer SAFE Solution to Stop Fraudulent E Commerce Merchants 5531 1OrbitalPay LLC Implements Zecures Acquirer SAFE Solution to Stop Fraudulent E Commerce Merchants 5531 2Unraveling the genetic picture of lung cancer 8496 1Unraveling the genetic picture of lung cancer 8496 2Biologists discover gene behind plant sex mystery 5529 1Biologists discover gene behind plant sex mystery 5529 2
...USINESS WIRE)--May 22, 2007 - Alequel(TM), an,indi... be an,effective treatment for moderate-to-severe ...ble-blind, placebo controlled Phase II,studies sug...od,clinical remissions and improved patients, qual...rs from Hebrew University-Hadassah,Medical Center,...
...ts importance of antiplatelet therapy compliance, ...PRNewswire-FirstCall/ -- Boston Scientific Corpora...ore than 7,000 patients from,its ARRIVE 1 and 2 re...e TAXUS(R) Express2(TM) paclitaxel- eluting corona...ctive of the analysis was,to identify baseline pre...
Other Medicine Technology:Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 2Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 3ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis,in Real-World Use of Drug-Eluting Stents 2ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis,in Real-World Use of Drug-Eluting Stents 3ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis,in Real-World Use of Drug-Eluting Stents 4
Eliminate preanalytical errors with automated QC module.
The TCM4 is able to detect patient changes and is portable.
Rapid exchange thrombectomy never handled like this before. ,Designed with tortuous anatomy in mind, the Spiroflex catheters unique spiral cut shaft, soft tip and hydrophilic coating provide out
Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2.
Medicine Products: